Keyphrases
Breast Cancer
60%
Early Breast Cancer
46%
Comprehensive Cancer Center
40%
Human Epidermal Growth Factor Receptor 2 (HER2)
26%
Expert Advice
20%
Delayed Breast Reconstruction
20%
Breast Cancer Genomics
20%
Human Epidermal Growth Factor Receptor 2-positive Breast Cancer
20%
Cancer in Pregnancy
20%
Obesity
20%
Pain Management
20%
First-line Therapy
20%
Quality of Life
20%
Docetaxel
20%
Positron Emission Tomography-computed Tomography (PET-CT)
20%
Symptomatology
20%
Retrospective Review
20%
Locally Advanced
20%
Trastuzumab
20%
Genomic Studies
20%
Copenhagen
20%
Locally Advanced Breast Cancer
20%
Neoadjuvant Chemotherapy
20%
Pain Characteristics
20%
Invasive Breast Cancer
20%
Malignant Disease
20%
Multigene
20%
Vinorelbine
20%
Pathological Complete Response
20%
Prospective Cross-sectional Study
16%
Advisory Board
13%
Hematology
13%
Health-related Quality of Life
13%
Oncology Patients
13%
Negative Breast Cancer
13%
Immunohistochemical Profile
13%
Predictive Value
13%
Oncology
13%
Estrogen Receptor-positive
13%
Non-theal
13%
Adjuvant Therapy
10%
Breast Cancer Symptoms
10%
Breast Cancer Risk
10%
Initial Staging
10%
Therapeutic Impact
10%
Cancer Mortality
10%
Breast Cancer Recurrence
10%
Diagnostic Impact
10%
New Primary
10%
Medical Advice
10%
Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
45%
Symptom
25%
Implant
20%
Locally Advanced Breast Cancer
20%
Neoadjuvant Chemotherapy
20%
Breast Reconstruction
20%
Positron Emission Tomography-Computed Tomography
20%
Disease
20%
Quality of Life
20%
Oncology
16%
Gamma Urogastrone
12%
Estrogen Receptor
12%
Prothrombin
12%
Hematology
12%
Symptomatology
12%
Diagnosis
10%
Breast Implant
6%
Cancer Mortality
6%
Adjuvant Therapy
6%
Cancer Diagnosis
5%